Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals.

Saved in:
Bibliographic Details
Title: Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals.
Authors: Uchino T; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan. uchinot@u-shizuoka-ken.ac.jp., Nakajo M; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Pharmacy, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Hatta I; Department of Research, Nagoya Industrial Science Research Institute, 1-13 Yotsuyadori, Chikusa-ku, Nagoya, 464-0819, Japan., Suzuki I; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan., Okada M; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan., Terada R; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan., Miyazaki Y; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Osawa M; Department of Pharmacy, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Taku K; Department of Oncology, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Yokoyama T; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Tsuji D; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Kagawa Y; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2026 Jan 19; Vol. 96 (1), pp. 8. Date of Electronic Publication: 2026 Jan 19.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0843
DOI:10.1007/s00280-025-04842-0